Enalapril vs Pembrolizumab

Enalapril vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Enalapril and Pembrolizumab.

Mechanism of Action

Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Enalapril — 11 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Enalapril — C20H28N2O5.

Molecular Weight: Enalapril — 376.4470 g/mol.

Type: Enalapril — Small molecule; Pembrolizumab — Antibody.